Trial intelligence / Profile preview

Pregabalin Release Tablets in Fibromyalgia

NCT02868814Phase 3Unknown

Sponsor
Hengrui
Start
May 2016
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of pregabalin in fibromyalgia (FM), sponsored by Hengrui. Status: unknown.

02

Drugs

pregabalin
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT02868814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02868814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call